Omalizumab administration in Churg-Strauss syndrome

European Journal of Internal Medicine

Volumn 20, Issue 6, 2009, Pages

  Giavina Bianchi, Pedro ^a   Kalil, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti IgE; Asthma; Churg Strauss syndrome; Difficult to control asthma; Eosinophil; Omalizumab

Indexed keywords

CORTICOSTEROID DERIVATIVE; OMALIZUMAB;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHURG STRAUSS SYNDROME; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DRUG DOSE REDUCTION; EOSINOPHIL COUNT; HUMAN; LETTER;

ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; CHURG-STRAUSS SYNDROME; HUMANS;

EID: 70349266715     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.12.008     Document Type: Letter

References (3)

1. Giavina-Bianchi P., Giavina-Bianchi M., Agondi R., and Kalil J. Omalizumab and Churg-Strauss syndrome. J Allergy Clin Immunol 122 (2008) 217
2. Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J. Anti-IgE administration in Churg-Strauss syndrome. Thorax in press.
3. Puéchal X., Rivereau P., and Vinchon F. Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med 19 (2008) 364-366